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ABSTRACT 
Objective: To investigate the antioxidant, antimicrobial, antiproliferative activities and in silico drug likeness prediction of the MHH compound. 
Methods: The antioxidant, antimicrobial and antiproliferative activities of the MHH compound have been evaluated by 1,1-Diphenyl-2-picryl hydrazyl 
(DPPH) and Ferric Reducing Antioxidant Power (FRAP) assays, agar well diffusion assay and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium 
bromide (MTT) assay respectively. The cytotoxicity activity and in silico drug likeness prediction of the MHH compound have been studied.  
Results: The DPPH radical scavenging activity and the total antioxidant power of the MHH compound were found to be 92.48%±2.06 and 
10.698±0.23 mM Fe (II)/g respectively. The antimicrobial activity of MHH compound against Escherichia coli, Klebsiella pneumonia, Proteus vulgaris, 
Salmonella typhi, Staphylococcus aureus and Streptomyces griseus, Candida albicans, Aspargillus flavus and the zones of inhibition were found to be 
16.83 mm, 19.83 mm, 15.23 mm, 16.79 mm, 13.57 mm, 19.65 mm, 18.66 mm and 14.79 mm respectively. The IC50 values of the MHH compound for 
HeLa and HCT-15 cell lines were found to be 371.92 μg/ml and 112.06 μg/ml respectively. The LC50 value of MHH compound was 218.765µg/ml 
and 152.78µg/ml which is considered as moderately cytotoxic and toxic respectively when incubated at 24 h and 48 h. The drug likeness and 
bioactivity scores of the MHH compound were found to be within the range and followed Lipinski’s rule.  
Conclusion: This study concludes that the MHH compound has significant biological activities and can be used as the therapeutic agent. 
Keywords: Millingtonia hortensis, MHH compound, Flavonoid, Antioxidant, Antimicrobial, Antiproliferative, Drug likeness. 
 
INTRODUCTION 
The biological activities of flavonoids and their derivatives depend 
upon the total number of hydroxyl groups, substitution of functional 
groups configuration and the degree of polymerization [1, 2]. Studies 
have reported the protective activities of flavonoid compounds 
against infectious diseases caused by bacteria, fungi and virus [3, 4]. 
Flavanoids also exhibit protective activities against degenerative 
diseases such as cancer, cardiovascular and other age related 
diseases [5, 6]. Many flavonoid compounds are reported to have 
antioxidant activities by scavenging free radicals or by chelating 
metal ions [7, 8].  
Reported that the isolated compounds kaempferol-3-O-(6β-O-galloyl-β-
D-glucopyranoside), kaempferol-3-O-β-D-glucopyranoside, quercetin-3-
O-β-D-glucopyranoside, and quercetin-3-O-(6β-O-galloyl-β–D-gluco 
pyranoside) showed significant DPPH radical scavenging assay than 
ethanolic crude extract [9]. 4,4'-dihydroxy-2'-meth-oxy-3'-prenyl is 
active towards Staphylococcus aureus [10], 5,7-dihydroxy-3,8-dimethoxy 
flavone against Staphylococcus epidermis [11] and 5,7,2',6'-tetrahydroxy-
6-prenyl-8-lavandulyl-4'-methoxy-flavanone inhibits the complete 
growth of Staphylococcus aureus [12].  
A flavone 7-(2''-sulphato glucoside (luteolin), an antifungal 
compound of marine angiosperm Thalassia testudinum [13]. Twelve 
cytotoxic flavonoids: two biflavans, three flavones and seven flavans 
which were cytotoxic isolated from Muntingia calabura roots were 
reported [14]. Three cytotoxic benzyl dihydro flavonols: 8-p-
hydroxy benzyl taxifolin, 6,8-di-p-hydroxy benzyl taxifolin and 6-p-
hydroxy benzyl taxifolin were isolated from Cudrania tricuspidata 
bark which was cytotoxic towards tumor cell lines like MOLT-4F, 
LOX-IMVI CRL 1579, UO-3 and KM12 [15]. The flavones 4',7''-di-O-
methyl amen to flavone and 7''-O-methyl robusta flavone were 
cytotoxic against colon, lung, breast and prostate cancer, leukemia 
cell lines[16]. The flavonol, quercetagetin 6,7,3',4'-tetramethyl ether 
from Artemisia annua was having significant cytotoxic activity 
against HT-29, P-388, KB, A549 and MCF-7 cell lines [17]. Two 
highly methylated flavones 5,6,7,8,3',4'-hexamethoxy flavone and 
5,6,7,8,4'-pentamethoxy flavone inhibited the proliferation of HTB43 
and 9L cell lines [18]. 
Drug likeness can be defined as the calculation of structural, 
molecular properties of a drug and determining the drug 
potentiality. In silico drug likeness and bioactivity score prediction 
can be carried out using various online tools such as Molinspiration, 
ADMET Predictor from Simulations Plus, Osiris drug like property 
calculator and Qik Prop from Schrodinger.  
The methanolic leaf extract of Millingtonia hortensis was subjected to 
silica gel column chromatography and was analyzed by thin layer 
chromatography (TLC) and high performance liquid 
chromatography (HPLC). The fraction that showed potential 
antioxidant, antimicrobial and antiproliferative activities was 
designated as S6. The S6 fraction was characterized by UV-Visible 
spectroscopy, fourier transform-infra red (FT-IR), liquid 
chromatography-mass spectroscopy (LC-MS) and nuclear magnetic 
resonance (NMR) spectroscopic techniques. From the above data, 
the structure of the compound was proposed as 5,7-dihydroxy-2-(4-
hydroxyphenyl)-6-methoxy-4H-chromen-4-one (Hispidulin) and 
named as MHH [19]. The objective of the present investigation is to 
evaluate the antioxidant, antimicrobial, antiproliferative, cytotoxicity 
activities and in silico drug likeness prediction of the purified MHH 
compound obtained from the methanolic leaf extract of Millingtonia 
hortensis Linn. 
MATERIALS AND METHODS 
Chemicals 
Foetal Bovine Serum (FBS), Minimal Essential Medium (MEM, 
GIBCO), trypsin solution (0.1%), 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide (MTT), 1,1-Diphenyl-2-picryl hydrazyl 
(DPPH), 2,4,6-tri-(2-pyridyl)-triazine (TPTZ) were purchased from 
Sigma Chemical Co. Saint Louis, Missouri, USA. Ascorbic acid, 
butylated hydroxyl toluene (BHT) rutin and di methyl sulfoxide 
(DMSO) was purchased from Merck, Germany. The other chemicals 
and solvents used were of analytical grade. 
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Test microorganisms 
The test microorganisms used for antimicrobial activity were 
Staphylococcus aureus (MTCC 96), Escherichia coli (MTCC 727), 
Streptomyces griseus (MTCC 3474), Proteus vulgaris (MTCC 744), 
Salmonella typhi (MTCC 734), Klebsiella pneumonia (MTCC 9544), 
Candida albicans (MTCC 3958) and Aspargillus flavus (MTCC 893). 
These bacterial and fungal strains were obtained from Microbial 
Type Culture Collection and Gene Bank (MTCC), Chandigarh. The 
bacterial cultures were maintained on LB nutrient agar slants and 
fungal cultures on Potato dextrose agar (PDA).  
Cell lines 
Colon cancer (HCT-15) and cervical cancer (HeLa) cell lines were 
procured from National Centre for Cell Science, Pune. The cells were 
grown in Minimal Essential Medium (MEM, GIBCO) supplemented 
with 4.5 g/l glucose, 100 μg/ml of penicillin and streptomycin, 2 mM 




Determination of free radical scavenging using DPPH method 
DPPH radical scavenging activity of the MHH compound was measured 
by the method as described [20-23]. The samples were prepared in 
triplicate for each analysis. BHT and Rutin were used as standards.  
Determination of ferric reducing antioxidant power assay (FRAP) 
FRAP assay of the MHH compound was carried out according to the 
method as described [24]. Ascorbic acid was used as standard.  
Antibacterial activity 
Antibacterial activity of the MHH compound was tested using agar 
well diffusion method as described [25-27]. 50 µl (0.2 mg/ml) of the 
MHH compound was used as the test, streptomycin & 
chloramphenicol (10µg) were used as positive controls and di 
methyl sulfoxide (DMSO) as negative control. The experiment was 
carried out in triplicates.  
Antifungal activity 
The antifungal activity of the MHH compound was carried out by agar 
well diffusion method as described [25-27]. 50 µl (0.2 mg/ml) of the 
MHH compound was used as the test, fluconazole & nystatin (10µg) 
were used as positive controls and di methyl sulfoxide (DMSO) as 
negative control. The experiment was carried out in triplicates.  
Determination of minimum inhibitory concentration (MIC) 
The minimum inhibitory concentration of the MHH compound was 
determined using agar well diffusion assay as described [27]. The 
MHH compound was loaded into the wells at different 
concentrations. The lowest concentration of the MHH compound 
that inhibited the growth of microorganism was considered as MIC. 
Antiproliferative activity 
Antiproliferative activity of the MHH compound was determined by 
MTT colorimetric assay as described by Mosmann (1983) with some 
modifications [28]. 12.5 µl, 25 µl, 50 µl, 100μl, 200μl (1 mg/ml) of 
the MHH compound was used as test, 5-fluoro uracil and Cisplatin 
were used as positive controls for antiproliferative activity. The 
experiment was carried out in triplicates.  
Cytotoxicity assay of the MHH compound using brine shrimp 
(Artema salina) 
Cytotoxicity assay of the MHH compound was performed by the 
method as described by Meyer et al., 1992 [29] by using different 
concentrations of the MHH compound (50, 100, 150, 200, 250 
µg/ml). Different concentrations of cyclophosphamide (20, 40, 60, 
80, 100, 120µg/ml) were used as positive control and artificial 
seawater as negative control. 
LC50 Determination 
The lethal concentration fifty (LC50), 95% confidence interval and 
slope were determined. Using the probit analysis method described 
[30], the mortality rates at 24h and 48h were used for LC50 
determination.  
Drug likeness and Bioactivity Score using in silico studies 
Lipinski’s Rule 
Lipinski's rule of five also known as the Pfizer's rule of five is a rule 
to evaluate drug likeness. It determines whether a chemical 
compound with assured pharmacological or biological activity has 
properties that would make it a likely orally active drug in humans. 
This rule describes the molecular properties which are important for 
a drug's pharmacokinetics in the human body including their 
absorption, distribution, metabolism and excretion ("ADME”).  
The rule states that most "drug-like" molecules have logP</= 5, 
molecular weight</= 500, number of hydrogen bond acceptors</= 
10 and the number of hydrogen bond donors</= 5. Molecules 
violating more than one of these rules may have problems with 
bioavailability. The rule is called "Rule of 5" because the border 
values are 5, 500, 2*5, and 5 [31, 32]. 
Molinspiration software 
Molinspiration, a web based software (www. molinspiration. com) used 
to obtain parameters such as mi Log P, total polar surface area (TPSA), 
drug likeness. Mi Log P, is calculated as a sum of fragment based 
contributions and correction factors which is used to check good 
permeability across the cell membrane [33]. Total polar surface area 
(TPSA) which relates to hydrogen bonding potential of particular 
molecule and is a very good predictor of drug transport properties such 
as bioavailability, intestinal absorption, and blood brain barrier 
penetration etc, Calculation of volume is based on group contributors. 
Number of rotatable bonds measures molecular flexibility which is a 
very good descriptor of absorption and bioavailability of drugs [34].  
Drug likeness score 
The drug likeness score of MHH compound was calculated by 
considering mi Log P (partition coefficient), molecular weight, 
number of heavy atoms, number of hydrogen acceptor, number of 
hydrogen donor and number of violation, number of rotatable bonds 
and volume.  
Bioactivity score 
Bioactivity of the MHH compound was checked by calculating the 
activity score of GPCR ligand, ion channel modulator, nuclear 
receptor ligand, kinase inhibitor, protease inhibitor, enzyme 
inhibitor with the help of software [35].  
RESULTS AND DISCUSSION 
DPPH Radical scavenging assay 
The free radical scavenging ability of the MHH compound was 
evaluated by DPPH radical scavenging assay as shown in fig. 1. The 
results showed that DPPH radical scavenging activity of the MHH 
compound was 92.48%±2.06. 
 
 
Fig. 1: Free radical scavenging ability of the MHH compound 
 
DPPH scavenging activity of crude methanolic extract, MHH 
compound, BHT and Rutin (10µg) was determined and expressed as 
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% of inhibition. Each value represents mean±SD of three 
independent experiments. The values are significant at p<0.05. 
Total antioxidant activity by FRAP method 
Total antioxidant power of the MHH compound was evaluated by 
FRAP method and results were expressed as mM Fe (II) equivalents 
per gram as shown in fig. 2. The ferric reducing power of MHH 
compound was found to be 10.698±0.23 mM Fe (II)/g.  
 
Fig. 2: Total antioxidant power of the MHH compound 
 
Total antioxidant activity of crude methanolic extract, MHH 
compound and ascorbic acid (10µg) were determined and expressed 
as % of inhibition. Each value represents mean±SD of three 
independent experiments. The values are significant at p<0.05. 
Antimicrobial activity & Determination of MIC 
The antimicrobial activity and minimum inhibitory concentration of 
the purified MHH compound against tested microorganisms was 
determined by agar well diffusion method and the results were 
presented in fig.–3, 4 and 5 respectively. 
 
 
Fig. 3: Antibacterial activity of the MHH compound 
 
Antibacterial activity of MHH compound, Streptomycin and 
Chloramphenicol (10µg) were determined and expressed as zone of 
inhibition (mm). Each value represents mean±SD of three 
independent experiments. The values are significant at p<0.05. 
 
 
Fig. 4: Antifungal activity of the MHH compound 
Antifungal activity of MHH compound, Fucanazole and Nystatin 
(10µg) were determined and expressed as zone of inhibition (mm). 
Each value represents mean±SD of three independent experiments. 
The values are significant at p<0.05. 
 
 
Fig. 5: Minimum Inhibitory concentration (MIC) of the MHH 
compound 
 
Anti-proliferative activity of the MHH Compound 
A linear correlation was observed between concentrations and 
percentage of inhibition of cell proliferation. An IC50 value for HeLa 
and HCT-15 cell lines was found to be 371.92 μg/ml and 112.06 
μg/ml respectively. The survival rate of HeLa cells was higher than 
that of HCT-15 cells at the same concentration of the MHH 
compound. In presence of MHH compound, cells aggregation was 
observed and most of the cells contain uncharacterized bodies, this 
may be due to the induction of apoptosis (fig. 7b & 9b). From the 
values of MHH compound against HeLa and HCT-15 cell lines, these 
studies suggests that the MHH compound can be used as an anti-
proliferative agent.  
 
 
Fig. 6: Effect of the MHH compound on HeLa cell lines. 
 
Cytotoxicity assay of the MHH compound 
The data represented shows that the MHH compound (24 h and 48 h 
incubation time) has cytotoxicity towards brine shrimp nauplii. This 
compound is considered to be cytotoxic because of its ability to kill 
the brine shrimp nauplii as dose concentration increased from 
50µg/ml to 250µg/ml. The MHH compound showed moderate 
lethality to brine shrimp nauplii at 200µg/ml with 60% at 24 h and 
70% at 48 h. The LC50 value of MHH compound was 218.765µg/ml 
when incubated at 24 h, which is considered as moderate 
cytotoxicity. At 48 h incubation, the LC 50 exhibits toxicity with an 
LC50 value of 152.78µg/ml. 
The MHH compound showed more toxicity at 48 h compared to 24 h 
with respect to positive control. This clearly shows that the MHH 
compound was toxic in terms of more incubation time. The positive 
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control cyclophosphamide showed the highest value in this test. 
LC50 value of cyclophosphamide was 76.92µg/ml and 71.25µg/ml at 
24 h and 48 h respectively which is highly toxic. No lethality of brine 
shrimp nauplii was observed with negative control. 
 
  
a-Untreated HeLa cells b-MHH treated HeLa cells 
Fig. 7: Microscopic observation of HeLa cell growth before and after treatment with the MHH compound 
 
 
Fig. 8: Effect of the MHH compound on HCT-15 cell lines 
 
  
a-Untreated HCT-15 cells b-MHH treated HCT-15 cells 
Fig. 9: Microscopic observation of HCT-15 cell growth before and after treatment with the MHH compound 
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Score for LC50 
<100 µg/ml   highly toxic,  
 Up to 200 µg/ml   toxic,  
 200-1000 µg/ml  moderately toxic and potential to be developed 
>1000 µg/ml   non-toxic 
 
Drug likeness and bioactivity score 
In the present study, the drug-likeness and bioactivity scores of the 
MHH compound compared with standards such as Quercetin, BHT, 
Rutin and Ascorbic acid and were predicted using Molinspiration, a 
web based software (www. molinspiration. com). 
Physico–chemical properties 
The physico-chemical properties of the MHH compound and the 
standards such as Quercetin, BHT, Rutin and Ascorbic acid were 
predicted and represented in the table 1. 
Drug likeness score 
The MHH compound obeyed the Lipinski’s rule and showed good drug 
likeness score which was represented in the table 2. Mi Log P values of 
the MHH compound was found to be 2.479, it shows good permeability 
across the cell membrane as mi Log P value was below 5. TPSA value of 
the MHH compound was found to be 100.129 which were below 160 Ǻ2.  
The MHH compound was found to have the number of hydrogen 
bond acceptors and number of hydrogen bond donors 6 and 3 
respectively which were found to be within Lipinski’s limit i.e. less 
than 10 and 5 respectively. The molecular weight of the MHH 
compound was 300.266 daltons which was less than 500 daltons. 
Bioactivity score 
The MHH compound showed good bioactivity score as per the rule 
and was represented in the table 3. For organic molecules the 
probability of the bioactivity score is>0 then it is active, if-5.0 to 0.0 
then moderately active, if<-5.0 then inactive. 
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Table 1: Physico–chemical properties of the MHH compound and standards 
Compound  Molecular Formula Melting Point (°C) Solubility IUPAC Name 
MHH 
compound 






Quercetin  C15H10O 316 7 DMSO Ethanol 2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy chromen-4-one  
BHT  C15H24 71 O Ethanol 2,6-ditert-butyl-4-methylphenol  








Ascorbic acid  C6H8O 191 6 Chloroform (2R)-2-[(1S)-1,2-dihydroxyethyl]-3,4-dihydroxy-2H-furan-
5-one  
 
Table 2: Drug likeness score of the MHH compound and Standards 
Compound  miLogP   TPSA  nAtoms  n ON  nOHNH  n Viola-tion  n rotb.  Volume   MW  
MHH compound  2.479  100.129   22.0   6   3   0   2  249.594  300.266 
Quercetin   1.683  131.35   22.0   7   5   0   1  240.084  302.238 
BHT   5.435  20.228   16.0   1   1   1   2  240.996  220.356  
Rutin  -1.063  269.427   43.0  16   10   3   6  496.068  610.521 
Ascorbic acid  -1.402  107.217   12.0   6   4   0   2  139.707  176.124  
 
Table 3: Bioactivity score of the MHH compound and Standards 














-0.07  -0.22   0.21   0.20  -0.33  0.17  
Quercetin  -0.06  -0.19   0.28   0.36  -0.25  0.28  
BHT  -0.34   0.00  -0.48  -0.08  -0.57  -0.07 
Rutin  -0.05  -0.52  -0.14  -0.23  -0.07  0.12  
Ascorbic acid  -0.53  -0.24  -1.09  -1.01  -0.81  0.20  
 The probability of bioactivity score of the MHH compound towards kinase inhibitor, nuclear receptor ligand, enzyme inhibitor was 0.21, 0.20 and 
0.17 (>0) respectively which was shown to be active and GPCR ligand, ion channel modulator, protease inhibitor was-0.07,-0.22 and-0.33 
respectively which showed to be moderately active (-5.0 to 0.0). 
 
CONCLUSION 
The antioxidant, antimicrobial and antiproliferative activities of the 
MHH compound were obtained high when compared to the crude 
extract and showed significant fold increase. The cytotoxicity studies 
on brine shrimp nauplii showed that the MHH compound was 
moderately toxic at 24 h incubation and found to be toxic when 
incubated for 48hr. The drug likeness and bioactivity scores of the 
MHH compound using in silico studies were calculated and found to be 
within the range. This study concludes that the MHH compound has 
significant biological activities and can be used as the therapeutic 
agent. 
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